Compare A & ROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | A | ROP |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.0B | 48.4B |
| IPO Year | 1999 | 1992 |
| Metric | A | ROP |
|---|---|---|
| Price | $145.28 | $447.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | $162.29 | ★ $600.23 |
| AVG Volume (30 Days) | ★ 2.1M | 809.3K |
| Earning Date | 11-24-2025 | 10-23-2025 |
| Dividend Yield | 0.70% | ★ 0.81% |
| EPS Growth | 3.16 | ★ 6.17 |
| EPS | 4.57 | ★ 14.52 |
| Revenue | $6,948,000,000.00 | ★ $7,721,000,000.00 |
| Revenue This Year | $7.76 | $13.76 |
| Revenue Next Year | $6.24 | $8.74 |
| P/E Ratio | $31.84 | ★ $30.83 |
| Revenue Growth | 6.73 | ★ 13.95 |
| 52 Week Low | $96.43 | $435.42 |
| 52 Week High | $160.27 | $595.17 |
| Indicator | A | ROP |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 43.79 |
| Support Level | $144.22 | $439.96 |
| Resistance Level | $160.27 | $449.80 |
| Average True Range (ATR) | 4.43 | 6.35 |
| MACD | -0.81 | 2.24 |
| Stochastic Oscillator | 25.16 | 77.57 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.